• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性冠状动脉综合征患者入院时推荐的血脂控制目标的先前依从情况。

Prior adherence to recommended lipid control targets in patients admitted for acute coronary syndrome.

机构信息

Unidad Coronaria, Servicio de Cardiología, Hospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, CIBERCV, Barcelona, Spain.

Unidad Coronaria, Servicio de Cardiología, Hospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, CIBERCV, Barcelona, Spain.

出版信息

Rev Esp Cardiol (Engl Ed). 2020 May;73(5):376-382. doi: 10.1016/j.rec.2019.06.014. Epub 2019 Nov 6.

DOI:10.1016/j.rec.2019.06.014
PMID:31706709
Abstract

INTRODUCTION AND OBJECTIVES

Optimal lipid control is difficult to attain. We assessed preadmission achievement of the European Society of Cardiology targets for low-density lipoprotein-cholesterol (LDL-C) control in patients admitted for acute coronary syndrome.

METHODS

Fasting LDL-C levels were measured in 3164 patients admitted between 2010 and 2017. We assessed the frequency of adequate LDL-C control, with targets defined according to individual cardiovascular risk, and the predictors of inadequate control.

RESULTS

The median LDL-C value was 104 (80-130) mg/dL. Most patients had high or very high cardiovascular risk and only 34.2% had LDL-C levels below the recommended target for their estimated risk. Achievement of LDL-C goals increased moderately throughout the study period. Adequate LDL-C control was inversely associated with patient risk. Dyslipidemia, active smoking, diabetes mellitus, and body mass index ≥ 25 were independent predictors of inadequate lipid control, while ongoing statin therapy was associated with adequate control.

CONCLUSIONS

Only slightly more than one third of patients admitted for acute coronary syndrome meet recommended LDL-C targets on admission. There is broad scope for improvement in primary and secondary prevention, especially among patients who are overweight or have other cardiovascular risk factors.

摘要

简介和目的

实现理想的血脂控制较为困难。我们评估了因急性冠脉综合征入院患者入院前低密度脂蛋白胆固醇(LDL-C)控制达到欧洲心脏病学会目标的情况。

方法

在 2010 年至 2017 年间,我们测量了 3164 例入院患者的空腹 LDL-C 水平。我们评估了 LDL-C 控制充分的频率,目标根据个体心血管风险定义,并评估了控制不充分的预测因素。

结果

LDL-C 值中位数为 104(80-130)mg/dL。大多数患者具有高或极高心血管风险,仅有 34.2%的患者 LDL-C 水平低于其估计风险的推荐目标。在整个研究期间,LDL-C 目标的达标率适度增加。LDL-C 控制充分与患者风险呈反比。血脂异常、主动吸烟、糖尿病和 BMI≥25 是血脂控制不充分的独立预测因素,而持续他汀类药物治疗与控制充分相关。

结论

仅略多于三分之一的因急性冠脉综合征入院的患者在入院时达到 LDL-C 目标。在一级和二级预防中仍有很大的改进空间,尤其是超重或有其他心血管危险因素的患者。

相似文献

1
Prior adherence to recommended lipid control targets in patients admitted for acute coronary syndrome.急性冠状动脉综合征患者入院时推荐的血脂控制目标的先前依从情况。
Rev Esp Cardiol (Engl Ed). 2020 May;73(5):376-382. doi: 10.1016/j.rec.2019.06.014. Epub 2019 Nov 6.
2
Risk Factors Associated with Failure to Achieve the Low Density Lipoprotein Cholesterol Therapeutic Target in Patients with Acute Coronary Syndrome: A Longitudinal, Single Centre Investigation.急性冠状动脉综合征患者低密度脂蛋白胆固醇治疗目标未达标的相关危险因素:一项纵向单中心研究
High Blood Press Cardiovasc Prev. 2019 Feb;26(1):37-43. doi: 10.1007/s40292-019-00298-5. Epub 2019 Jan 25.
3
Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.法国冠心病患者低密度脂蛋白胆固醇目标未达最佳水平。来自DYSIS II ACS/CHD研究的当代数据。
Arch Cardiovasc Dis. 2017 Mar;110(3):167-178. doi: 10.1016/j.acvd.2016.11.004. Epub 2017 Feb 13.
4
Lipid management in ACS: Should we go lower faster?急性冠脉综合征中的血脂管理:我们是否应该更快地降低血脂?
Atherosclerosis. 2018 Aug;275:368-375. doi: 10.1016/j.atherosclerosis.2018.06.871. Epub 2018 Jun 22.
5
Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design.旨在支持急性冠状动脉综合征(IDEAL-LDL)患者 LDL-C 治疗目标和降脂治疗依从性的动机性访谈研究:原理和设计。
Hellenic J Cardiol. 2019 Jul-Aug;60(4):249-253. doi: 10.1016/j.hjc.2018.10.002. Epub 2018 Oct 21.
6
Role of Lipid-Lowering Therapy in Low-Density Lipoprotein Cholesterol Goal Attainment: Focus on Patients With Acute Coronary Syndrome.降脂治疗在 LDL-C 达标中的作用:关注急性冠脉综合征患者。
J Cardiovasc Pharmacol. 2020 Dec;76(6):658-670. doi: 10.1097/FJC.0000000000000914.
7
Characteristics of lipid profile and effectiveness of management of dyslipidaemia in patients with acute coronary syndromes - Data from the TERCET registry with 19,287 patients.急性冠状动脉综合征患者的血脂特征及血脂异常管理效果 - 来自 TERCET 注册登记研究的 19287 例患者数据。
Pharmacol Res. 2019 Jan;139:460-466. doi: 10.1016/j.phrs.2018.12.002. Epub 2018 Dec 6.
8
Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe.急性和慢性冠心病患者 LDL-胆固醇靶值达标情况的预测因素不同:来自 DYSIS II Europe 的结果。
Eur J Prev Cardiol. 2018 Dec;25(18):1966-1976. doi: 10.1177/2047487318806359. Epub 2018 Oct 18.
9
Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome: a Danish population-based cohort study.降脂治疗与急性冠状动脉综合征后 LDL-C 目标达标:一项丹麦基于人群的队列研究。
BMC Cardiovasc Disord. 2020 Jul 13;20(1):336. doi: 10.1186/s12872-020-01616-9.
10
Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.稳定性或急性冠心病患者的胆固醇目标值达标和降脂治疗:来自血脂异常国际研究 II 的结果。
Atherosclerosis. 2017 Nov;266:158-166. doi: 10.1016/j.atherosclerosis.2017.08.013. Epub 2017 Aug 21.

引用本文的文献

1
Factors Associated with Medication Non-Adherence in Patients with Dyslipidemia.血脂异常患者药物治疗不依从性的相关因素
Healthcare (Basel). 2021 Jun 28;9(7):813. doi: 10.3390/healthcare9070813.
2
Factors Associated with the Prescribing of High-Intensity Statins.与高强度他汀类药物处方相关的因素
J Clin Med. 2020 Nov 27;9(12):3850. doi: 10.3390/jcm9123850.